These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15660582)

  • 1. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease.
    Stenvinkel P; Lindholm B; Heimbürger O
    Semin Dial; 2004; 17(6):505-15. PubMed ID: 15660582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition and wasting in renal disease.
    Muscaritoli M; Molfino A; Bollea MR; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):378-83. PubMed ID: 19474712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients.
    Yao Q; Lindholm B; Stenvinkel P
    Hemodial Int; 2004 Apr; 8(2):118-29. PubMed ID: 19379407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients.
    Maruyama Y; Stenvinkel P; Lindholm B
    Blood Purif; 2005; 23(4):275-81. PubMed ID: 15925866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inflammation and nutrition in patients with end-stage renal disease.
    Don BR; Kaysen GA
    J Nephrol; 2000; 13(4):249-59. PubMed ID: 10946803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V67-72. PubMed ID: 15284363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in end-stage renal disease: the hidden enemy.
    Stenvinkel P
    Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease.
    Noori N; Kopple JD
    Semin Dial; 2010; 23(2):178-84. PubMed ID: 20525107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on inflammation in chronic kidney disease.
    Akchurin OM; Kaskel F
    Blood Purif; 2015; 39(1-3):84-92. PubMed ID: 25662331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms.
    Nordfors L; Lindholm B; Stenvinkel P
    J Intern Med; 2005 Jul; 258(1):1-12. PubMed ID: 15953127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition, inflammation and chronic kidney disease.
    Ikizler TA
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):162-7. PubMed ID: 18277149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.